Post-earnings recap
Reported
Tue, Apr 23, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported a better-than-expected EPS of $1.40, leading to a significant stock increase of 9.27%. The lack of revenue data and guidance may leave investors with questions, but the EPS surprise indicates positive performance in the quarter.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.40 | N/A | +1.96% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.